NASDAQ:AERI
Delisted

Aerie Pharmaceuticals Stock News

etoro logo Buy AERI
*Your capital is at risk
$15.25
+0 (+0%)
At Close: Feb 17, 2023
Aerie (AERI) is progressing well with the development of its ophthalmology pipeline. Its partnership with Santen Pharmaceuticals allows it to expand the presence of its drugs outside the United States

93 Biggest Movers From Friday

09:25am, Monday, 28'th Feb 2022 Benzinga
Gainers Inspirato Incorporated (NASDAQ: ISPO ) shares surged 50.5% to close at $54.90. Guardforce AI Co., Limited (NASDAQ: GFAI ) jumped 45.4% to settle at $0.5979 on Friday. EF Hutton recently initiated coverage on the stock with a Buy rating and a $2 price target. CarGurus, Inc. (NASDAQ: CARG ) shares gained 44% to close at $46.44 after the company reported better-than-expected Q4 results. Farfetch Limited (NYSE: FTCH ) climbed 39.4% to close at $20.92 after the company reported better-than-expected Q4 EPS results. TD Holdings, Inc. (NASDAQ: GLG ) gained 38.9% to settle at $0.25 amid overall market strength as investors react to the ongoing Russia-Ukraine conflict. KAR Auction Services, Inc. (NYSE: KAR ) shares climbed 38.4% to close at $18.94 after the company agreed to sell its ADESA U.S. physical auction business to Carvana for $2.2 billion. Guggenheim upgraded KAR Auction Services from Sell to Neutral. Imperial Petroleum Inc. (NASDAQ: IMPP ) gained 33.8% to close at $2.10. Universal Security Instruments, Inc. (NYSE: UUU ) climbed 32.9% to close at $3.96 after the company reported a joint merger deal with Infinite Reality.
The Aerie Pharmaceuticals Inc (NASDAQ: AERI) stock increased by 29.49% in the most recent trading session. This is why.

45 Stocks Moving In Friday''s Mid-Day Session

05:02pm, Friday, 25'th Feb 2022 Benzinga
Gainers KAR Auction Services, Inc. (NYSE: KAR ) shares climbed 39.2% to $19.05 after the company agreed to sell its ADESA U.S. physical auction business to Carvana for $2.2 billion. Guggenheim upgraded KAR Auction Services from Sell to Neutral. CarGurus, Inc. (NASDAQ: CARG ) shares jumped 38% to $44.51 after the company reported better-than-expected Q4 results. Cyren Ltd. (NASDAQ: CYRN ) shares jumped 37.9% to $6.55 after gaining around 119% on Thursday. Cyren regained compliance with Nasdaq listing requirements. Farfetch Limited (NYSE: FTCH ) gained 26.7% to $19.02 after the company reported better-than-expected Q4 EPS results. Universal Security Instruments, Inc. (NYSE: UUU ) jumped 23% to $3.6796 after the company reported a joint merger deal with Infinite Reality. Paramount Group, Inc. (NYSE: PGRE ) gained 22.2% to $11.35. BVK and Paramount Joint Venture acquired M&M''s World Flagship Store at 1600 Broadway for $191.5 million. Aerie Pharmaceuticals, Inc. (NASDAQ: AERI ) surged 21.3% to $7.16 as the company swung to a profit in the fourth quarter.

AERI stock gains as company swings to profits in Q4 (AERI)

03:46pm, Friday, 25'th Feb 2022 Seeking Alpha
Aerie Pharmaceuticals <> is trading sharply higher in morning hours to record the biggest intraday gain since 2017 after the commercial-stage pharma company…
Aerie Pharmaceuticals (AERI) +25%. Schrodinger (SDGR) +17%. Baudax Bio BXRX -55%. The Joint (JYNT) -15%.
Aerie Pharmaceuticals, Inc. (AERI) CEO Raj Kannan on Q4 2021 Results - Earnings Call Transcript
Aerie Pharmaceuticals press release (AERI): Q4 Non-GAAP EPS of $1.09 beats by $1.77.Revenue of $114.7M (+364.4% Y/Y) beats by $83.54M.Outlook: Glaucoma franchise net product…
DURHAM, N.C.--(BUSINESS WIRE)--Aerie Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

Aerie Pharmaceuticals appoints Gary Sternberg as medical chief

11:53am, Thursday, 24'th Feb 2022 Seeking Alpha
Aerie Pharmaceuticals (AERI) said Gary Sternberg will join the company as chief medical officer, effective Mar. 1.

Aerie Pharmaceuticals Q4 2021 Earnings Preview

10:35pm, Wednesday, 23'rd Feb 2022 Seeking Alpha
Aerie Pharmaceuticals (NASDAQ:AERI) is scheduled to announce Q4 earnings results on Thursday, February 24th, after market close.The consensus EPS Estimate is -$0.68 (+13.9% Y/Y) and…

Why Did Aerie Pharmaceuticals Inc. (NASDAQ: AERI) Drop So Much?

03:00pm, Wednesday, 23'rd Feb 2022 Stocks Register
Aerie Pharmaceuticals Inc. (NASDAQ:AERI) traded at $5.82 at close of the session on Tuesday, 02/22/22, made a downward move of -3.00% on its previous days price. Looking at the stock we see that its previous close was $6.00 and the beta (5Y monthly) reads 0.85 with the days price range being $5.79 $6.075. In Why Did Aerie Pharmaceuticals Inc. (NASDAQ: AERI) Drop So Much? Read More »
Let us take a look at five biotech/drug companies, namely, MRNA, EDIT, VIR, EBS and AERI, which are due to release their quarterly results on Feb 24.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE